Abstract:Pyridomycin, a cyclodepsipeptide with potent antimycobacterial activity, specifically inhibits the InhA enoyl reductase of Mycobacterium tuberculosis. Structure-activity relationship studies indicated that the enolic acid moiety in the pyridomycin core system is an important pharmacophoric group, and the natural configuration of the C-10 hydroxyl contributes to the bioactivity of pyridomycin. The ring structure of pyridomycin was generated by the nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) hybrid system (PyrE-PyrF-PyrG). Bioinformatics analysis reveals that short-chain dehydrogenase/reductase (SDR) family protein Pyr2 functions as a 3-oxoacyl acyl carrier protein (ACP) reductase in the pyridomycin pathway. Inactivation of pyr2 resulted in accumulation of pyridomycin B, a new pyridomycin analogue featured with enol moiety in pyridyl alanine moiety and a saturated 3-methylvaleric acid group. The elucidated structure of pyridomycin B suggests that rather than functioning as a post-tailoring enzyme, Pyr2 catalyzes ketoreduction to form the C-10 hydroxyl group in pyridyl alanine moiety and the double bond formation of the enolic acid moiety derived from isoleucine when the intermediate assembled by PKS-NRPS machinery is still tethered to the last NRPS module in a special energy-saving manner. Ser-His-Lys residues constitute the active site of Pyr2, which is different from the typically conserved Tyr-based catalytic triad in the majority of SDRs. Site-directed mutation identified that His154 in the active site is a critical residue for pyridomycin B production. These findings will improve our understanding of pyridomycin biosynthetic logic, identify the missing link for the double bound formation of enol ester in pyridomycin, and enable the creation of chemical diversity of pyridomycin derivatives. IMPORTANCE Tuberculosis (TB) is one of the world's leading causes of death by infection. Recently, pyridomycin, the antituberculous natural product from Streptomyces has garnered considerable attention for being determined as a target inhibitor of InhA enoyl reductase of Mycobacterium tuberculosis. In this study, we report a new pyridomycin analogue from mutant HTT12, demonstrate the essential role of a previously ignored gene pyr2 in pyridomycin biosynthetic pathway, and imply that Pyr2 functions as a trans ketoreductase (KR) contributing to the formation of functional groups of pyridomycin utilizing a distinct catalytic mechanism. As enol moiety are important for pharmaceutical activities of pyridomycin, our work would expand our understanding of the mechanism of SDR family proteins and set the stage for future bioengineering of new pyridomycin derivatives.

Identification and Characterization of the Pyridomycin Biosynthetic Gene Cluster of Streptomyces Pyridomyceticus NRRL B-2517.

Identification and Characterization of the Pyridomycin Biosynthetic Gene Cluster of Streptomyces pyridomyceticus

Functional Characterization of Pyrg, an Unusual Nonribosomal Peptide Synthetase Module from the Pyridomycin Biosynthetic Pathway

Identification and Functional Analysis of Gene Cluster Involvement in Biosynthesis of the Cyclic Lipopeptide Antibiotic Pelgipeptin Produced by Paenibacillus Elgii

The Biosynthetic Gene Cluster of Pyrazomycin-A C-Nucleoside Antibiotic with a Rare Pyrazole Moiety

Characterization of the biosynthesis gene cluster for the pyrrole polyether antibiotic calcimycin (A23187) in Streptomyces chartreusis NRRL 3882.

Identification of the gene cluster involved in muraymycin biosynthesis from Streptomyces sp. NRRL 30471.

Characterization of Pyridomycin B Reveals the Formation of Functional Groups in Antimycobacterial Pyridomycin

Characterization of the Cyclodipeptide Synthase Gene Cluster in Streptomyces Sp. NRRL F-5123 by Unraveling the Biosynthesis of Drimentine B

A novel 7-O-α-L-rhamnopyranosyl genistein isolated from Streptomyces pyridomyceticus NRRL B-2517,the producer of pyridomycin

Identification and Analysis of the Biosynthetic Gene Cluster Encoding the Thiopeptide Antibiotic Cyclothiazomycin in Streptomyces Hygroscopicus 10-22

Identification of the Biosynthetic Pathway for the Antibiotic Bicyclomycin.

Biosynthesis Of The Pyrrolidine Protein Synthesis Inhibitor Anisomycin Involves Novel Gene Ensemble And Cryptic Biosynthetic Steps

A Complete Gene Cluster From Streptomyces Nanchangensis Ns3226 Encoding Biosynthesis Of The Polyether Ionophore Nanchangmycin

Identification of the Tirandamycin Biosynthetic Gene Cluster from Streptomyces Sp. 307-9.

Biosynthetic pathway of peucemycin and identification of its derivative from Streptomyces peucetius

Construction of a Bacterial Artificial Chromosome Library for a Myxobacterium of the GenusCystobacterand Characterization of an Antibiotic Biosynthetic Gene Cluster

Insights into pyrroindomycin biosynthesis reveal a uniform paradigm for tetramate/tetronate formation.

Identification and Heterologous Expression of the Kendomycin B Biosynthetic Gene Cluster from Verrucosispora sp. SCSIO 07399

Cloning and Characterization of the Biosynthetic Gene Cluster of the Bacterial RNA Polymerase Inhibitor Tirandamycin from Marine-Derived Streptomyces Sp. SCSIO1666

Identification Of The Pyranonigrin A Biosynthetic Gene Cluster By Genome Mining In Penicillium Thymicola Ibt 5891